The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life

Roy Fleischmann

Open Access Rheumatology: Research and Reviews 2009, 1:95-106

Published Date: 14 July 2009